PMID- 38314749 OWN - NLM STAT- MEDLINE DCOM- 20240207 LR - 20240211 IS - 2164-554X (Electronic) IS - 2164-5515 (Print) IS - 2164-5515 (Linking) VI - 20 IP - 1 DP - 2024 Dec 31 TI - Factors associated with HPV vaccine hesitancy among college students: A cross-sectional survey based on 3Cs and structural equation model in China. PG - 2309731 LID - 10.1080/21645515.2024.2309731 [doi] LID - 2309731 AB - Despite the high effectiveness of HPV vaccines in preventing infection, vaccine hesitancy remains a concern, particularly in China. This study aimed to explore college students' attitudes toward HPV vaccination and identify associated factors. Data was collected through a cross-sectional survey using self-administered questionnaires in four cities from May to June 2022. Chi-square tests and logistic regression analyses were conducted to identify factors. Additionally, an integrated structural equation model (SEM) based on the 3Cs (confidence, convenience, complacency) was developed to understand underlying factors contributing to hesitancy. The results from 2261 valid questionnaires were enlightening. A significant 89.47% (59.4% for females) considered HPV vaccination necessary, with 9.82% remaining neutral and only 0.71% deeming it unnecessary. Factors like higher education, being a medical student, residing in urban areas, having medical insurance, more extraordinary living expenses, a family history of tumors, and a solid understanding of HPV played a role in perceiving the vaccine as necessary. Among the 1438 female respondents, 84.36% had no hesitancy toward HPV vaccination, 13.53% expressed hesitancy, and 2.11% refused vaccination. Factors like age, understanding of HPV, medical staff recommendations, living expenses, and family history influenced hesitancy levels. SEM revealed that the 3Cs significantly affected vaccine hesitancy. Factors like price, booking process, vaccination times, trust in vaccines, medical staff recommendations, efficiency, and risk perception collectively influenced hesitancy. In conclusion, this study found high acceptance of HPV vaccination but acknowledged the complexity of hesitancy factors. It recommends medical staff disseminate scientific knowledge, offer recommendations, simplify booking procedures, and expand vaccination sites to address vaccine hesitancy effectively. FAU - Chen, Cheng AU - Chen C AD - School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. FAU - Chen, Ting AU - Chen T AD - School of Public Health, Wuhan University of Science and Technology, Wuhan, China. FAU - Huang, Mingzhao AU - Huang M AD - School of Public Health, Wuhan University of Science and Technology, Wuhan, China. AD - Hubei Key Laboratory of Occupational Disease Hazard Identification and Control, Wuhan, China. FAU - Huang, Yan AU - Huang Y AD - Center for Chinese Public Administration Research, School of Government, Sun Yat-sen University, Guangzhou, China. FAU - Zhang, Luying AU - Zhang L AD - School of Public Health, Fudan University, Shanghai, China. FAU - Li, Pindong AU - Li P AD - Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. AD - Institute of Radiation Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. AD - Hubei Key Laboratory of Precision Radiation, Wuhan, China. LA - eng PT - Journal Article DEP - 20240205 PL - United States TA - Hum Vaccin Immunother JT - Human vaccines & immunotherapeutics JID - 101572652 RN - 0 (Papillomavirus Vaccines) SB - IM MH - Humans MH - Female MH - Cross-Sectional Studies MH - *Papillomavirus Infections/prevention & control MH - Vaccination Hesitancy MH - China MH - *Students, Medical MH - *Papillomavirus Vaccines MH - Vaccination MH - Health Knowledge, Attitudes, Practice MH - Patient Acceptance of Health Care PMC - PMC10854271 OTO - NOTNLM OT - 3C model OT - Vaccine hesitancy OT - college students OT - human papilloma virus OT - structural equation model COIS- No potential conflict of interest was reported by the author(s). EDAT- 2024/02/05 14:44 MHDA- 2024/02/07 06:42 PMCR- 2024/02/05 CRDT- 2024/02/05 08:43 PHST- 2024/02/07 06:42 [medline] PHST- 2024/02/05 14:44 [pubmed] PHST- 2024/02/05 08:43 [entrez] PHST- 2024/02/05 00:00 [pmc-release] AID - 2309731 [pii] AID - 10.1080/21645515.2024.2309731 [doi] PST - ppublish SO - Hum Vaccin Immunother. 2024 Dec 31;20(1):2309731. doi: 10.1080/21645515.2024.2309731. Epub 2024 Feb 5.